Keith Danahey

Adoption of a clinical pharmacogenomics implementation program during outpatient care–initial results of the University of Chicago “1,200 Patients Project”

Peter H. O’Donnell, Keith Danahey, Michael Jacobs et al. · American Journal of Medical Genetics Part C Seminars in Medical Genetics · 2014 · 128 citations · Full text

T cell receptor- and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells.

Jean E. Maguire, Keith Danahey, Linda C. Burkly et al. · The Journal of Experimental Medicine · 1995 · 93 citations · Full text

Cell Adhesion, Immunology, Cytoskeleton +20

Pharmacogenomics‐Based Point‐of‐Care Clinical Decision Support Significantly Alters Drug Prescribing

PH O'Donnell, Nisha R. Wadhwa, Keith Danahey et al. · Clinical Pharmacology & Therapeutics · 2017 · 86 citations · Full text

Pharmacotherapy, Adverse Drug Reaction, Clinical Epidemiology +16

COVIDOSE: A Phase II Clinical Trial of Low‐Dose Tocilizumab in the Treatment of Noncritical COVID‐19 Pneumonia

Garth W. Strohbehn, Brian L. Heiss, Sherin J. Rouhani et al. · Clinical Pharmacology & Therapeutics · 2020 · 58 citations · Full text

Inflammation, Clinical Immunology, Noncritical Covid‐19 Pneumonia +15

Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs

Amy L. Kaufman, Jared Spitz, Michael Jacobs et al. · Mayo Clinic Proceedings · 2015 · 50 citations · Full text

Heart Failure, Cardiovascular Disease, Pharmacology +6